554 results match your criteria: "Centre cardiologique du Nord[Affiliation]"
J Cardiothorac Vasc Anesth
November 2024
Department of Cardiology, Centre Cardiologique du Nord, Saint Denis, France.
Eur Heart J
November 2024
Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, Ontario, Canada.
Background And Aims: Severe tricuspid regurgitation is associated with increased mortality rates, but benefit of its correction and ideal timing are not clearly determined. This study aimed to identify patient subsets who might benefit from the surgery.
Methods: In TRIGISTRY, an international cohort study of consecutive patients with severe isolated functional tricuspid regurgitation (33 centres, 10 countries), survival rates up to 10 years were compared between patients who underwent isolated tricuspid valve surgery (repair or replacement) and those conservatively managed, overall and according to TRI-SCORE category (low: ≤3, intermediate: 4-5, and high: ≥6).
Heart
September 2024
Univ Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, Rennes, France.
Background: The best management of symptomatic patients with low-gradient (LG) severe aortic stenosis (AS) and preserved left ventricular ejection fraction (LVEF) has not been established. The Randomised study for the Optimal Treatment of symptomatic patients with low-gradient severe Aortic valve Stenosis (ROTAS) trial aimed to assess the superiority of aortic valve replacement (AVR) versus medical treatment (MT) in this specific group of AS patients.
Methods: Patients with symptomatic LG severe AS and preserved LVEF (>50%) underwent dobutamine stress echocardiography and/or CT-aortic calcium score to confirm AS severity and were then randomised 1:1 to AVR or MT.
JACC Cardiovasc Interv
August 2024
Medizinische Klinik und Poliklinik I, Ludwig-Maximilians University Klinikum, Ludwig-Maximilians University München, Munich, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany. Electronic address:
JACC Cardiovasc Interv
September 2024
Cardiology Department, Centre Cardiologique du Nord, Saint-Denis, France.
Arch Cardiovasc Dis
September 2024
Inserm U942, Paris Cité University, AP-HP, Hôpital Lariboisière, 75010 Paris, France.
Background: Acute heart failure (AHF) is a leading cause of hospitalization and mortality - especially in patients aged≥65 years in high-income countries - and represents a high healthcare burden. In the past decade, the epidemiology and management of heart failure (HF) has changed, with the emergence of new medical and interventional therapeutics, but up-to-date real-life data are scarce.
Aims: The main objectives are to describe baseline characteristics (with an emphasis on lifestyle, cognitive status, HF knowledge and treatment adherence), management, and in-hospital and mid-term outcomes of AHF patients in France.
Arch Cardiovasc Dis
October 2024
RESICARD, Heart Failure Network, 75011 Paris, France; Department of Cardiology, Saint-Antoine and Tenon Hospitals, AP-HP, Sorbonne Université, 75012 Paris, France; INSERM UMRS 1166, Institute of Cardiometabolism and Nutrition (ICAN), Sorbonne Université, 75012 Paris, France. Electronic address:
Background: Heart failure is associated with reduced quality of life, hospitalizations, death and high healthcare costs. Despite care improvements, the rehospitalization rate after an acute heart failure episode, especially for acute heart failure, remains high.
Methods: The Education Strategy for patients with acute Heart Failure (EduStra-HF; ClinicalTrials.
Microorganisms
July 2024
Department of Cardiac Surgery, Centre Cardiologique du Nord, 93200 Saint-Denis, France.
Native valve infective endocarditis (NVE) is a global phenomenon, defined by infection of a native heart valve and involving the endocardial surface. The causes and epidemiology of the disease have evolved in recent decades, with a doubling of the average patient age. A higher incidence was observed in patients with implanted cardiac devices that can result in right-sided infection of the tricuspid valve.
View Article and Find Full Text PDFInt J Mol Sci
July 2024
Department of Cardiac Surgery, Centre Cardiologique du Nord, 93200 Saint-Denis, France.
Platelets play a significant role in hemostasis, forming plugs at sites of vascular injury to limit blood loss. However, if platelet activation is not controlled, it can lead to thrombotic events, such as myocardial infarction and stroke. To prevent this, antiplatelet agents are used in clinical settings to limit platelet activation in patients at risk of arterial thrombotic events.
View Article and Find Full Text PDFAnn Cardiol Angeiol (Paris)
September 2024
Transcatheter aortic valve implantation (TAVI) has established as a gold standard in the treatment of elderly patients with severe aortic stenosis. Vascular access marks the first step in a TAVI procedure where the transfemoral access is preferred. Therefore, vascular complications are one of the main concerns of operators.
View Article and Find Full Text PDFJ Am Coll Cardiol
July 2024
Cardiothoracic Surgery, Lancashire Cardiac Centre/Blackpool Teaching Hospital, Blackpool, United Kingdom.
JACC Cardiovasc Interv
July 2024
Cardiovascular Research Foundation, New York, NY, USA; Department of Clinical Physiology and Echocardiography, Heart Valve Clinic, CHU Lille, Lille, France. Electronic address:
J Interv Card Electrophysiol
December 2024
Centre Cardiologique du Nord, Saint-Denis, France.
Background: The combination of highly localized impedance (LI) and contact force (CF) may improve tissue characterization and lesion prediction during radiofrequency (RF) pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF).
Objective: We report the outcomes of our acute and long-term clinical evaluation of CF-LI-guided PVI in consecutive AF ablation cases from an international multicenter clinical setting.
Methods: Three hundred twenty-four consecutive patients from 20 European centers undergoing RF catheter ablation with the Stablepoint™ catheter were enrolled in the CHARISMA registry.
Eur J Cardiothorac Surg
July 2024
Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Surg Technol Int
July 2024
Department of Cardiac Surgery, Centre Cardiologique du Nord, Saint-Denis, France.
The Ross procedure is often considered the best option for a small group of patients. Some critics argue that harvesting the pulmonary artery again can cause problems, such as exposing the native pulmonary autograft to systemic pressures and requiring further intervention. However, the pulmonary autograft is a living tissue that can adjust to growing conditions and undergo remodelling.
View Article and Find Full Text PDFJ Thorac Dis
May 2024
Department of Cardiovascular Surgery, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, China.
Background: Despite improvements in management, infective endocarditis (IE) is still associated with high mortality and morbidity. The outcome of patients with IE remains unclear in high-altitude areas of China. To characterize the epidemiological features and surgical outcomes, a retrospective analysis was conducted to 221 patients diagnosed with IE from a single center.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
August 2024
Cardiology Department, Centre Cardiologique du Nord, Saint Denis, France.
Background: Radial access is the default approach in interventional cardiology. The Axiostat® surgical hemostatic dressing, using chitosan as its active component, has demonstrated potential in accelerating blood clotting. This study aims to assess the efficacy and the safety of the Axiostat® dressing in achieving hemostasis in patients undergoing transradial coronary angioplasty (TRCA).
View Article and Find Full Text PDFEur Heart J Cardiovasc Imaging
July 2024
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Canada.
Eur Heart J Cardiovasc Imaging
September 2024
Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Canada.
Aims: As transcatheter mitral valve (MV) interventions are expanding and more device types and sizes become available, a tool supporting operators in pre-procedural planning and the clinical decision-making process is highly desirable. We sought to develop a finite element computational simulation model to predict the results of transcatheter edge-to-edge repair (TEER) interventions.
Methods And Results: We prospectively enrolled patients with secondary mitral regurgitation (MR) referred for a clinically indicated TEER.
BJS Open
May 2024
Department of Medicine, South-Karelia Central Hospital, University of Helsinki, Lappeenranta, Finland.
JACC Cardiovasc Interv
June 2024
Department of Cardiology, University of Ottawa Heart Institute, Ottawa, Canada. Electronic address:
World J Surg
July 2024
Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Arch Cardiovasc Dis
May 2024
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON K1Y 4W7, Canada. Electronic address:
Background: Transcatheter (TAVR) has supplanted surgical (SAVR) aortic valve replacement (AVR).
Aim: To evaluate whether adoption of this technology has varied according to centre volume at the nationwide level.
Methods: From an administrative hospital-discharge database, we collected data on all AVRs performed in France between 2007 and 2019.